Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial

MLA

Coelen, Robert J. S., et al. “Endoscopic versus Percutaneous Biliary Drainage in Patients with Resectable Perihilar Cholangiocarcinoma: A Multicentre, Randomised Controlled Trial.” The Lancet Gastroenterology & Hepatology, vol. 3, no. 10, Oct. 2018, pp. 681–90. EBSCOhost, https://doi.org/10.1016/S2468-1253(18)30234-6.

APA

Coelen, R. J. S., Roos, E., Wiggers, J. K., Besselink, M. G., Buis, C. I., Busch, O. R. C., Dejong, C. H. C., van Delden, O. M., van Eijck, C. H. J., Fockens, P., Gouma, D. J., Koerkamp, B. G., de Haan, M. W., van Hooft, J. E., IJzermans, J. N. M., Kater, G. M., Koornstra, J. J., van Lienden, K. P., Moelker, A., … van Gulik, T. M. (2018). Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial. The Lancet Gastroenterology & Hepatology, 3(10), 681–690. https://doi.org/10.1016/S2468-1253(18)30234-6

Chicago

Coelen, Robert J S, Eva Roos, Jimme K Wiggers, Marc G Besselink, Carlijn I Buis, Olivier R C Busch, Cornelis H C Dejong, et al. 2018. “Endoscopic versus Percutaneous Biliary Drainage in Patients with Resectable Perihilar Cholangiocarcinoma: A Multicentre, Randomised Controlled Trial.” The Lancet Gastroenterology & Hepatology 3 (10): 681–90. doi:10.1016/S2468-1253(18)30234-6.